Key Factors that Promote Low-Value Care: Views of Experts From the United States, Canada, and the Netherlands

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 35

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_HPM-11-8_028

تاریخ نمایه سازی: 17 مرداد 1403

Abstract:

Background  Around the world, policies and interventions are used to encourage clinicians to reduce low- value care. In order to facilitate this, we need a better understanding of the factors that lead to low-value care. We aimed to identify the key factors affecting low-value care on a national level. In addition, we highlight differences and similarities in three countries. Methods  We performed ۱۸ semi-structured interviews with experts on low-value care from three countries that are actively reducing low-value care: the United States, Canada, and the Netherlands. We interviewed ۵ experts from Canada, ۶ from the United States, and ۷ from the Netherlands. Eight were organizational leaders or policy-makers, ۶ as low-value care researchers or project leaders, and ۴ were both. The transcribed interviews were analyzed using inductive thematic analysis. Results  The key factors that promote low-value care are the payment system, the pharmaceutical and medical device industry, fear of malpractice litigation, biased evidence and knowledge, medical education, and a ‘more is better’ culture. These factors are seen as the most important in the United States, Canada and the Netherlands, although there are several differences between these countries in their payment structure, and industry and malpractice policy.Conclusions  Policy-makers and researchers that aim to reduce low-value care have experienced that clinicians face a mix of interdependent factors regarding the healthcare system and culture that lead them to provide low-value care. Better awareness and understanding of these factors can help policy-makers to facilitate clinicians and medical centers to deliver high-value care.

Authors

Eva W. Verkerk

Department of IQ Healthcare, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands

Simone A. Van Dulmen

Department of IQ Healthcare, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands

Karen Born

Institute for Health Policy, Management & Evaluation, University of Toronto, Toronto, ON, Canada

Reshma Gupta

University of California Health, Sacramento, CA, USA

Gert Westert

Department of IQ Healthcare, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands

Rudolf B. Kool

Department of IQ Healthcare, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands